CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $343,628,607
- in 74 filings, $342.8M under 10b5-1 plans
Net −$343,628,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −528 | $587.42 | $310K | 333,415 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −493 | $588.61 | $290K | 332,922 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −603 | $589.80 | $356K | 332,319 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,657 | $590.65 | $979K | 330,662 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,181 | $591.56 | $1.3M | 328,481 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −518 | $592.61 | $307K | 327,963 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −245 | $593.81 | $145K | 327,718 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,275 | $594.65 | $758K | 326,443 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,040 | $595.41 | $619K | 325,403 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −480 | $596.65 | $286K | 324,923 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $597.48 | $263K | 324,483 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $598.83 | $24K | 324,443 |
| 2026-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 24,410 | ||
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −159 | $587.00 | $93K | 333,784 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −323 | $588.30 | $190K | 333,461 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −427 | $589.21 | $252K | 333,034 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −359 | $590.11 | $212K | 332,675 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −317 | $591.10 | $187K | 332,358 |
Page 1 of 127 · 2,532 trades